Skip to main content
Back All courses

Gastrointestinal Oncology

Separator

18 courses availables

Gastrointestinal Oncologydottime30 min

First- and second-line chemotherapy options in mPDAC

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Chemotherapy strategies for metastatic pancreatic ductal adenocarcinoma

Module 2 of 2
eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Diagnosis and management of metastatic pancreatic ductal adenocarcinoma

Module 1 of 2
eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Understanding the needs of different patient populations in CRC

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

胃腸および肝臓腫瘍に対する標的療法に関連する皮膚毒性 (JA)

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Long term management of advanced colorectal cancer

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

**TEST** (NOT VALID)

TEST TEST
eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Проявления кожной токсичности, связанные с таргетной терапией рака ЖКТ и печени (RU)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Exploring the current gastroesophageal cancer treatment landscape and near-future developments

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

NEW - Skin Toxicities Related to Targeted Therapy in GI and Liver Oncology

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Toxicidades cutáneas relacionadas con la terapia dirigida en oncología hepática y gastrointestinal (ES)

eaccme EACCME®accme ACCMEabim ABIM
Gastrointestinal Oncologydottime60 min

Marco de Comunicación GUIDE (ES)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Skin Toxicities Related to Targeted Therapy in GI and Liver Oncology

eaccme EACCME®accme ACCMEabim ABIM
Gastrointestinal Oncologydottime60 min

Impact of TRIBE-2, Re-ARRANGE and FOxTROT data in colorectal cancer on sequential clinical practice

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

GUIDE Communication Framework

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

How long should treatment of colorectal cancer be within an adjuvant setting: 3 or 6 months?

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

The SHARE 5 Step Communication Framework for Shared Decision-Making in 3rd-Line Treatment of Metastatic Colorectal Cancer (mCRC)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Treatment Sequencing and Flexible Dosing in Later-Line Management of Colorectal Cancer

eaccme EACCME®